Nurix Therapeutics, Inc. posts $-180.36 million annual loss

Nurix Therapeutics, Inc. [NRIX]  has posted annual loss of $-180.36 million for the year ended Nov 30,2022.

The company based in California(CA)reported a risein revenue to $38.63 milion for the year when compared to $29.75 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Feb 9,2023 showed that its revenue is  down 29.84% year-over-year.

The company reported basic earnings per share of $-3.71 and diluted earnings per share of $48607990.

Nurix Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.